Fred Hassan

Fred Hassan founded Caret Pharma LLC in 2017 and IM HealthScience LLC in 2010, where he is working as Chairman from 2010.
Mr. Hassan also founded Caret Group LLC, where he is working as Chairman.
Mr. Hassan also currently works at Saghmos Therapeutics, Inc., as Chairman from 2023, Physician's Seal LLC, as Non-Executive Chairman, Precigen, Inc., as Independent Director from 2016, Cocrystal Pharma, Inc., as Independent Director from 2023, BridgeBio Pharma, Inc., as Independent Director from 2021, EyePoint, Inc., as Independent Director from 2024, The Business Council, as Member, and Caerus Ventures LLC, as Advisor.
Mr. Hassan also formerly worked at Merck & Co., Inc., as Chairman, President & Chief Executive Officer from 2003 to 2009, Pharmacia & Upjohn, Inc., as President & Chief Executive Officer from 1997 to 2000, Schering-Plough Corp., as Chairman & Chief Executive Officer from 2003 to 2009, Pharmacia Corp., as Chairman & Chief Executive Officer from 2001 to 2003, Avon Products, Inc., as Non-Executive Chairman in 2013, Bausch & Lomb, Inc., as Non-Executive Chairman in 2013, Pharmaceutical Research & Manufacturers of America, as Chairman, Theramex HQ UK Ltd., as Chairman, Wyeth LLC, as Director & Executive Vice President from 1995 to 1997, Amgen, Inc., as Independent Director from 2015 to 2021, Electronic Data Systems Corp., as Director, Time Warner, Inc., as Independent Director from 2009 to 2018, Warburg Pincus LLC, as Managing Director, Bausch Health Cos., Inc., as Director from 2013 to 2014, Prometheus Biosciences, Inc., as Independent Director from 2021 to 2023, International Federation of Pharmaceutical Manufacturers, as President, Wyeth-Ayerst Laboratories, as President in 1993, and Sandoz Pharmaceuticals Corp., as Principal.
Mr. Hassan received his undergraduate degree from Imperial College London and Masters Business Admin degree from Harvard Business School.